These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 20466222)

  • 1. Platelet aspirin resistance in ED patients with suspected acute coronary syndrome.
    Glauser J; Emerman CL; Bhatt DL; Peacock WF
    Am J Emerg Med; 2010 May; 28(4):440-4. PubMed ID: 20466222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical importance of laboratory-defined aspirin resistance in patients presenting with non-ST elevation acute coronary syndromes.
    Acikel S; Yildirir A; Aydinalp A; Bal U; Kaynar G; Ozin B; Muderrisoglu H
    Blood Coagul Fibrinolysis; 2009 Sep; 20(6):427-32. PubMed ID: 19542882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspirin resistance determined from a bed-side test in patients suspected to have acute coronary syndrome portends a worse 6 months outcome.
    Chu JW; Wong CK; Chambers J; Wout JV; Herbison P; Tang EW
    QJM; 2010 Jun; 103(6):405-12. PubMed ID: 20356848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of aspirin resistance after percutaneous coronary intervention for acute myocardial infarction in predicting one-year major adverse coronary events.
    Marcucci R; Paniccia R; Antonucci E; Gori AM; Fedi S; Giglioli C; Valente S; Prisco D; Abbate R; Gensini GF
    Am J Cardiol; 2006 Nov; 98(9):1156-9. PubMed ID: 17056317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aspirin resistance and adverse clinical events in patients with coronary artery disease.
    Chen WH; Cheng X; Lee PY; Ng W; Kwok JY; Tse HF; Lau CP
    Am J Med; 2007 Jul; 120(7):631-5. PubMed ID: 17602938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance to low-dose aspirin therapy among patients with acute coronary syndrome in relation to associated risk factors.
    Salama MM; Morad AR; Saleh MA; Sabri NA; Zaki MM; ElSafady LA
    J Clin Pharm Ther; 2012 Dec; 37(6):630-6. PubMed ID: 23121257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measuring aspirin resistance, clopidogrel responsiveness, and postprocedural markers of myonecrosis in patients undergoing percutaneous coronary intervention.
    Buch AN; Singh S; Roy P; Javaid A; Smith KA; George CE; Pichard AD; Satler LF; Kent KM; Suddath WO; Waksman R
    Am J Cardiol; 2007 Jun; 99(11):1518-22. PubMed ID: 17531573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of association between the 807 C/T polymorphism of glycoprotein Ia gene and post-treatment platelet reactivity after aspirin and clopidogrel in patients with acute coronary syndrome.
    Cuisset T; Frere C; Quilici J; Morange PE; Saut N; Romero-Barra M; Camoin L; Lambert M; Juhan-Vague I; Bonnet JL; Alessi MC
    Thromb Haemost; 2007 Feb; 97(2):212-7. PubMed ID: 17264949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of mean platelet volume on prognosis of patients with and without aspirin resistance in settings of non-ST-segment elevated acute coronary syndromes.
    Aksu H; Ozer O; Unal H; Hobikoglu G; Norgaz T; Buturak A; Soylu O; Narin A
    Blood Coagul Fibrinolysis; 2009 Dec; 20(8):686-93. PubMed ID: 19730245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intensifying platelet inhibition with tirofiban in poor responders to aspirin, clopidogrel, or both agents undergoing elective coronary intervention: results from the double-blind, prospective, randomized Tailoring Treatment with Tirofiban in Patients Showing Resistance to Aspirin and/or Resistance to Clopidogrel study.
    Valgimigli M; Campo G; de Cesare N; Meliga E; Vranckx P; Furgieri A; Angiolillo DJ; Sabatè M; Hamon M; Repetto A; Colangelo S; Brugaletta S; Parrinello G; Percoco G; Ferrari R;
    Circulation; 2009 Jun; 119(25):3215-22. PubMed ID: 19528337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relation of low response to clopidogrel assessed with point-of-care assay to periprocedural myonecrosis in patients undergoing elective coronary stenting for stable angina pectoris.
    Cuisset T; Hamilos M; Sarma J; Sarno G; Wyffels E; Vanderheyden M; Barbato E; Bartunek J; De Bruyne B; Wijns W
    Am J Cardiol; 2008 Jun; 101(12):1700-3. PubMed ID: 18549843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The elder patient with suspected acute coronary syndromes in the emergency department.
    Han JH; Lindsell CJ; Hornung RW; Lewis T; Storrow AB; Hoekstra JW; Hollander JE; Miller CD; Peacock WF; Pollack CV; Gibler WB;
    Acad Emerg Med; 2007 Aug; 14(8):732-9. PubMed ID: 17567963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency of acute coronary syndrome in patients with normal electrocardiogram performed during presence or absence of chest pain.
    Turnipseed SD; Trythall WS; Diercks DB; Laurin EG; Kirk JD; Smith DS; Main DN; Amsterdam EA
    Acad Emerg Med; 2009 Jun; 16(6):495-9. PubMed ID: 19426294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and biologic profile of aspirin resistance in patients with angiographically proven coronary artery disease.
    Narvaez I; Sagastagoitia JD; Vacas M; Saez Y; Lafita M; Monica S; de Lafuente JP; Molinero E; Iriarte JA
    Thromb Res; 2007; 120(5):671-7. PubMed ID: 17331566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of upstream tirofiban versus downstream tirofiban on myocardial damage and 180-day clinical outcomes in high-risk acute coronary syndromes patients undergoing percutaneous coronary interventions.
    Liu T; Xie Y; Zhou YJ; Li YP; Ma HY; Guo YH; Liu YY; Zhao YX; Shi DM
    Chin Med J (Engl); 2009 Aug; 122(15):1732-7. PubMed ID: 19781316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose aspirin increases aspirin resistance in patients with coronary artery disease.
    Lee PY; Chen WH; Ng W; Cheng X; Kwok JY; Tse HF; Lau CP
    Am J Med; 2005 Jul; 118(7):723-7. PubMed ID: 15989905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Acetylsalicylic acid (ASA) resistance in patients with ischemic heart disease (IHD) as bioindicator of the treatment strategy].
    Malý J; Pecka M; Gregor J; Dulícek P; Blazek M; Malý R; Pudil R; Bláha M
    Cas Lek Cesk; 2005; 144 Suppl 3():23-9. PubMed ID: 16335259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective validation of the Thrombolysis in Myocardial Infarction Risk Score in the emergency department chest pain population.
    Chase M; Robey JL; Zogby KE; Sease KL; Shofer FS; Hollander JE
    Ann Emerg Med; 2006 Sep; 48(3):252-9. PubMed ID: 16934646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and risk factors for aspirin and clopidogrel resistance in patients with coronary artery disease or ischemic cerebrovascular disease.
    Kim H; Lee HK; Han K; Jeon HK
    Ann Clin Lab Sci; 2009; 39(3):289-94. PubMed ID: 19667414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergency physician high pretest probability for acute coronary syndrome correlates with adverse cardiovascular outcomes.
    Chandra A; Lindsell CJ; Limkakeng A; Diercks DB; Hoekstra JW; Hollander JE; Kirk JD; Peacock WF; Gibler WB; Pollack CV;
    Acad Emerg Med; 2009 Aug; 16(8):740-8. PubMed ID: 19673712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.